Author: admin

Continue Reading

  • Epigenetic regulators in cancer therapy and progression

    Epigenetic regulators in cancer therapy and progression

  • Bates, S. E. Epigenetic therapies for cancer. N. Engl. J. Med. 383, 650–663 (2020).

    PubMed 

    Google Scholar 

  • Waddington, C. H. The epigenotype. Int. J. Epidemiol. 41, 10–13 (2012).

    PubMed 

  • Continue Reading

  • User acceptance of battery swapping in battery electric vehicles among private users in Germany

    User acceptance of battery swapping in battery electric vehicles among private users in Germany

    As mentioned earlier, swappable batteries are not yet widespread in Germany and are unknown to large parts of the population. The following section, therefore, places particular focus on factors influencing the acceptance of e-mobility in general…

    Continue Reading

  • Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis

    Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis

    Chromosome Y loss in blood leukocytes is associated with the risk for IPF

    We first investigated IPF in relation to mLOY in the prospective UKB cohort with participants from the general population. Among 407,034 participants included in the present…

    Continue Reading

  • Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues

    Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues

    The role of the CDK4/6-RB pathway and cell cycle proteins in cancer

    Most adult tissues consist of G0 phase cells, either in a permanent state from terminal differentiation or senescence, or in a temporary, reversible state known as quiescence….

    Continue Reading